Inicio>>Signaling Pathways>> Immunology/Inflammation>> Interleukin Related>>Olokizumab

Olokizumab (Synonyms: CDP 6038; OKZ)

Catalog No.GC69621

Olokizumab (CDP 6038) es un anticuerpo monoclonal humanizado dirigido contra la interleucina-6 (IL-6). Olokizumab se puede utilizar en la investigación de la artritis reumatoide (RA).

Products are for research use only. Not for human use. We do not sell to patients.

Olokizumab Chemical Structure

Cas No.: 1007223-17-7

Tamaño Precio Disponibilidad Cantidad
5mg
648,00 $
Disponible
10mg
1.035,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Reseñas

Review for Olokizumab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Olokizumab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.